Sionna Therapeutics, Inc. Common Stock SION Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.78M-62.5% | -$20.44M-29.0% | -$20.28M+20.3% | -$18.07M-111% | -$16.48M-39.1% | ||
| $154K-3.1% | $152K-9.0% | $100K-50.0% | $100K-50.0% | $159K-4.2% | ||
| $6.55M+213% | $3.83M+260% | $3.31M+222% | $2.84M+192% | $2.09M+224% | ||
| $1.21M-66.0% | -$712K-166% | $567K+132% | -$3.83M— | $3.55M+113% | ||
| -$3.46M+19.8% | $2.49M-21.5% | —— | —— | -$4.32M-64.8% | ||
| -$740K-232% | $1.54M+164% | $0-100% | $161K-29.1% | $559K-55.0% | ||
| $489K-0.4% | $491K+0.2% | $490K0.0% | $490K0.0% | $491K-0.2% | ||
| -$543K-2.8% | -$543K-2.8% | -$529K-2.9% | -$528K-2.9% | -$528K-54.4% | ||
| -$21.84M-34.1% | -$16.63M-41.1% | -$15.23M+13.9% | -$18.15M-78.9% | -$16.29M-23.6% | ||
| $0-100% | $204K+656% | $87K— | $0— | $86K— | ||
| $25.33M-85.2% | $42.88M+496% | $54.14M+134% | $56.42M+97.1% | $171.6M+38.5% | ||
| $50.15M+64.5% | $65.67M+192% | $77.33M+131% | $33.17M— | $30.49M— | ||
| $24.82M+118% | —— | —— | -$23.25M+18.8% | -$141.19M-13.9% | ||
| $2.21M— | $1.66M+6,536% | $1.97M+2,604% | $6K-84.2% | $0-100% | ||
| $1.89M-99.1% | $1.66M— | $1.97M— | $0-100% | $202.39M+11.6% | ||
| $4.87M-89.1% | $7.62M— | $9.85M+219% | —— | $44.91M+1.5% | ||
| $200K-71.3% | $353K-55.3% | $836K-16.1% | $1.17M+5.7% | $697K+528% | ||
| $154K-3.1% | $152K-9.0% | $100K-50.0% | $100K-50.0% | $159K-4.2% | ||
| -$543K-2.8% | -$543K-2.8% | -$529K-2.9% | -$528K-2.9% | -$528K-54.4% | ||
| -$740K-232% | $1.54M+164% | $0-100% | $161K-29.1% | $559K-55.0% | ||
| $489K-0.4% | $491K+0.2% | $490K0.0% | $490K0.0% | $491K-0.2% | ||
| $50.15M+64.5% | $65.67M+192% | $77.33M+131% | $33.17M— | $30.49M— | ||
| $320K— | $0-100% | —— | —— | $0— | ||
| $0-100% | —— | —— | —— | $202.39M— | ||
| $0-100% | —— | —— | —— | $330.37M— | ||
| -$543K-2.8% | -$543K-2.8% | -$529K-2.9% | -$528K-2.9% | -$528K-54.4% | ||
| $265K-16.7% | —— | —— | —— | $318K— | ||
| $0-100% | —— | —— | —— | $4.27M— | ||
| $12K— | —— | —— | —— | $0— | ||
| -$21.84M-33.4% | -$16.83M-42.5% | -$15.32M+13.4% | -$18.15M-78.9% | -$16.37M-24.3% | ||
| -$21.84M-33.4% | -$16.83M-42.5% | -$15.32M+13.4% | -$18.15M-78.9% | -$16.37M-24.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.